The blood-brain barrier protects the brain from poisons but also prevents drugs from reaching brain tumors; innovative new treatments are needed.
This laboratory study shows that a nanotechnology drug called SapC-DOPS crosses that barrier and targets brain-tumor cells and retards growth of tumor blood vessels. The findings also show how the agent targets tumor cells and recommend its further development as a novel treatment for glioblastoma.
An experimental drug in early development for aggressive brain tumors can cross the blood-brain tumor barrier, kill tumor cells and block the growth of tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
The laboratory and animal study also shows how the agent, called SapC-DOPS, targets tumor cells and blood vessels. The findings support further development of the drug as a novel treatment for brain tumors.
Glioblastoma multiforme is the most common and aggressive form of brain cancer, with a median survival of about 15 months. A major obstacle to improving treatment for the 3,470 cases of the disease expected in the United States this year is the blood-brain barrier, the name given to the tight fit of cells that make up the blood vessels in the brain. That barrier protects the brain from toxins in the blood but also keeps drugs in the bloodstream from reaching brain tumors.
“Few drugs have the capacity to cross the tumor blood-brain barrier and specifically target tumor cells,” says principal investigator Balveen Kaur, PhD, associate professor of neurological surgery and chief of the Dardinger Laboratory of Neurosciences at the OSUCCC – James. “Our preclinical study indicates that SapC-DOPS does both and inhibits the growth of new tumor blood vessels, suggesting that this agent could one day be an important treatment for glioblastoma and other solid tumors.”
The findings were published in a recent issue of the journal Molecular Therapy.
SapC-DOPS (saposin-C dioleoylphosphatidylserine), is a nanovesicle drug that has shown activity in glioblastoma, pancreatic cancer and other solid tumors in preclinical studies. The nanovesicles fuse with tumor cells, causing them to self-destruct by apoptosis.
Key findings of the study, which used two brain-tumor models, include:
The Latest Bing News on:
- Uncovering anxiety: Scientists identify causative pathway and potential cureson February 23, 2024 at 6:41 am
Several studies have demonstrated the therapeutic effects of DOP agonists (synthetic compounds which selectively bind to DOPs and mimic the effect of the natural binding compound) in a wide range ...
- Brendan Gallagher Suspended Five Gameson January 25, 2024 at 4:00 pm
But Montreal ultimately pulled off the win in regulation. Now the NHL DOPS issued a suspension for Gallagher following a phone hearing related to that hit. Gallagher is a veteran forward for the ...
- The Dopson January 5, 2023 at 11:48 pm
Arrived Homes is an alternative investment platform that allows individuals to easily invest in real estate by purchasing shares of rental properties. Investors on the platform earn passive income ...
- Photography: Pick of the DoPson November 11, 2017 at 6:41 pm
To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...
- Six tips to better understand supplemental discipline in the NHLon October 16, 2016 at 5:00 pm
That couldn't be further from the truth, however. During the 2014-15 season I visited the NHL DOPS war room and learned everything I could about how suspensions happen. I've spent the next couple ...
The Latest Google Headlines on:
[google_news title=”” keyword=”SapC-DOPS” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
- Machine learning innovations and applications in nanotechnologyon February 28, 2024 at 3:59 pm
(Light, Science & Applications, " Emerging role of machine learning in light-matter interaction") ML-driven nanotechnology is at the forefront of biomedical innovations, from targeted drug delivery ...
- SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Pancreatic Canceron February 28, 2024 at 3:59 pm
SNB-101 is the world's first nanoparticle anticancer drug that has been developed extremely insoluble SN-38 into polymer nanoparticles. It has been approved for phase 1 clinical trials in the US ...
- Global Dermatological Drugs Market Set to Surpass US$30 Billion with Advanced Nanotechnology and Aging Population Fostering Growthon February 28, 2024 at 2:45 am
AMC Entertainment's (AMC) fourth-quarter 2023 results are likely to reflect year-over-year growth in attendance on the back of varied service offerings and new theatre openings globally.
- 4 Ways That Food Additives Affect Your Healthon February 27, 2024 at 11:02 am
Here are the four additives and what they do to your gut microbes.
- Dermatological Drugs Market Report 2024-2034 - Nanotechnology in Drug Delivery Could Revolutionize the Dermatological Drugs Marketon February 27, 2024 at 7:59 am
The "Dermatological Drugs Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for Dermatological Drugs Market, in terms of value is forecast to surpass US$30 ...
- Study reveals how innovative chemotherapy approach works against lung canceron February 26, 2024 at 11:42 am
Lung cancer is not the most frequent type of cancer but it is by far the most deadly Despite therapies such as surgery radiation therapy and chemotherapy o ...
- Global Magnetite Nanoparticles Market Is Expected To Reach US$ 191.4 Million By 2032: IMARC Groupon February 25, 2024 at 12:46 am
The latest report by IMARC Group, titled“ Magnetite Nanoparticles Market Report by Type (Iron Based, Cobalt Based), Phy ...
- Nanotechnology for targeted drug deliveryon February 24, 2024 at 2:18 pm
What is nanotherapy? Nanoparticles can be used in targeted drug delivery to improve the bioavailability, biodistribution, and accumulation of therapeutics, preferentially in the targeted diseased area ...
- New Nanotechnology-Based Drug for Metastatic Pancreatic Cancer Approved for Reimbursementon February 21, 2024 at 8:02 pm
A new drug against metastatic pancreatic cancer, which uses nanotechnology to reach the target, has been authorized for reimbursement by the Italian Drug Agency (Aifa). It is the first drug for a ...
- Drug Infused With Gold Nanocrystals May Reverse Parkinson's, Study Suggestson February 21, 2024 at 1:59 am
The findings could eventually help bring this treatment to patients with these and other neurodegenerative diseases, according to the authors.
The Latest Google Headlines on:
[google_news title=”” keyword=”nanotechnology drug” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]